MENU
OCT 13 - 15 2020

Thermo Fisher Scientific: The Power of Omics

The Power of Proteomics is a three-day Thermo Fisher Scientific virtual event that focuses on harnessing the power of omics to advance scientific research. The virtual event will feature a series of presentations, followed by roundtable discussions, from academia and industry-leading experts.

Sessions will include:

  • Areas of study from virion proteomics, structural analysis, protein interactomics and virus-host interactions and how these areas of research drive the development of vaccines and diagnostics
  • Areas of study including cancer pathway proteomics, proteogenomics, and immunopeptidomics as well as examples of standardization across laboratories
  • Several collaborations including single-cell proteomics, native MS for structural analysis, multiplexed proteomics and artificial intelligence that enable the mass analysis of proteins from any organism significantly faster than before and almost error-free
  • Roundtable discussions focused on challenges of delivering fast but quality science, what’s needed to accelerate discovery research through practical utility, and standards that will deliver the promise of proteomics for human health

In addition to the presentations, audiences can also visit our five virtual booths, where Thermo Fisher Scientific experts will be there to welcome you (virtually) and answer any questions you may have. There will also be a dedicated poster hall and the networking lounge where you can converse with other participants too!


Speakers

Show Resources
You May Also Like
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Please join us for this FREE workshop, as we present Agilent’s LC/MS hardware and software solutions for getting the most out of your analysis data....
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 11, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...
Agenda

 

 

  • Roundtable: Future needs in proteomics
    OCT 15, 2020 5:00 PM CEST
    Roundtable: Future needs in proteomics
    Dani Lopez Ferrer
    Senior Manager for Proteomics - Thermo Fisher
  • Speaker: TMT Research Award Winner
    OCT 15, 2020 4:00 PM CEST
    Speaker: TMT Research Award Winner
    Ryan Bomgarden
    Sr. R&D Manager - Thermo Fisher
  • Speaker: A Quantitative Proteome Map of the Human Body
    OCT 15, 2020 3:30 PM CEST
    Speaker: A Quantitative Proteome Map of the Human Body
    Lihua Jiang
    Director - Stanford University
  • Speaker: Deep learning architecture Prosit and its application in mass spectrometry-based proteomics
    OCT 15, 2020 3:00 PM CEST
    Speaker: Deep learning architecture Prosit and its application in mass spectrometry-based proteomics
    Mathias Wilhelm
    Chair of Proteomics and Bioanalytics - Technical University of Munich
  • Speaker: Characterizing Cellular Hierarchies Using Quantitative Single-Cell Proteomics
    OCT 15, 2020 2:30 PM CEST
    Speaker: Characterizing Cellular Hierarchies Using Quantitative Single-Cell Proteomics
    Erwin Schoof
    Associate Professor - Copenhagen University
  • Plenary Speaker: Measuring protein-level biology, one ion at a time
    OCT 15, 2020 1:00 PM CEST
    Plenary Speaker: Measuring protein-level biology, one ion at a time
    Neil Kelleher
    Glass Professor of Life Sciences - Northwestern University
  • Roundtable: Maximizing the use of proteomics data
    OCT 14, 2020 5:00 PM CEST
    Roundtable: Maximizing the use of proteomics data
    Bernhard Kuster
    Professor - Technical University of Munich
  • Speaker: SureQuant pTyr - a platform for targeted profiling of tyrosine phosphorylation signaling dynamics in human tumors
    OCT 14, 2020 4:00 PM CEST
    Speaker: SureQuant pTyr - a platform for targeted profiling of tyrosine phosphorylation signaling dynamics in human tumors
    Lauren Stopfer
    Graduate Student - Koch Institute for Integrative Cancer Research & MIT
  • Speaker: A proteogenomics approach to antigen discovery in cervical cancer
    OCT 14, 2020 3:30 PM CEST
    Speaker: A proteogenomics approach to antigen discovery in cervical cancer
    Nicola Ternette
    Associate Professor - University of Oxford
  • Speaker: Proteogenomics for discovery of targets and predictive markers for immunotherapy
    OCT 14, 2020 3:00 PM CEST
    Speaker: Proteogenomics for discovery of targets and predictive markers for immunotherapy
    Janne Lehtio
    Professor - Karolinska Institutet
  • Speaker: Ion mobility enhanced data independent acquisition and application to cancer proteomics
    OCT 14, 2020 2:30 PM CEST
    Speaker: Ion mobility enhanced data independent acquisition and application to cancer proteomics
    Lukas Reiter
    Chief Technology Officer - Biognosys AG
  • Plenary Speaker: Large Scale Melanoma Cancer Studies at the European Cancer Moonshot Lund Center in Partnership with Five International Clinical Hospitals
    OCT 14, 2020 1:00 PM CEST
    Plenary Speaker: Large Scale Melanoma Cancer Studies at the European Cancer Moonshot Lund Center in Partnership with Five International Clinical Hospitals
    Gyorgy Marko-Varga
    Professor - Lund University
  • Roundtable: Overcoming challenges of delivering fast but quality science and the collaborations needed to accelerate discovery research through to practical utility
    OCT 13, 2020 5:00 PM CEST
    Roundtable: Overcoming challenges of delivering fast but quality science and the collaborations needed to accelerate discovery research through to practical utility
    Andreas Hühmer
    Senior Marketing Director of Omics - Thermo Fisher Scientific
  • Speaker: The Global Phosphorylation Landscape of SARS-CoV-2 Infection
    OCT 13, 2020 4:00 PM CEST
    Speaker: The Global Phosphorylation Landscape of SARS-CoV-2 Infection
    Danielle Swaney
    Assistant Professor - UCSF
  • Speaker: High-throughput detection of SARS-CoV-2 by turbulent flow chromatography and tandem mass spectrometry
    OCT 13, 2020 3:30 PM CEST
    Speaker: High-throughput detection of SARS-CoV-2 by turbulent flow chromatography and tandem mass spectrometry
    Valdemir Melechco Carvalho
    Senior Scientist - Fleury Group
  • Speaker: Integrating transcriptomics and proteomics to study viral protein expression - finding new things to avoid unpleasant surprises
    OCT 13, 2020 3:00 PM CEST
    Speaker: Integrating transcriptomics and proteomics to study viral protein expression - finding new things to avoid unpleasant surprises
    David Matthews
    Reader in Virology - Uni Bristol
  • Speaker: Proteomic Investigation of COVID-19 Patient Specimens
    OCT 13, 2020 2:30 PM CEST
    Speaker: Proteomic Investigation of COVID-19 Patient Specimens
    Tiannan Guo
    Assistant Professor - Westlake University
  • Plenary Speaker: The Glycan Shield of Enveloped Viruses: from HIV to SARS-CoV-2
    OCT 13, 2020 1:00 PM CEST
    Plenary Speaker: The Glycan Shield of Enveloped Viruses: from HIV to SARS-CoV-2
    Max Crispin
    Professor of Glycobiology - University of Southampton, UK
Speakers

More speakers added daily!


  • Ryan Bomgarden
    Sr. R&D Manager - Thermo Fisher
    Biography

      Dr. Ryan Bomgarden received his bachelor’s degree from Coe College with majors in Chemistry and Molecular Biology before completing his Ph.D. at Stanford University under Dr. Karlene Cimprich where he worked on biochemical characterization of the checkpoint kinase ATR DNA binding activity and signaling in UV-sensitive human cell lines.

      In 2005, Dr. Bomgarden joined Pierce Biotechnology, now part of Thermo Fisher Scientific, where he has led the development of over a 100 new products including Tandem Mass Tag reagents for relative quantitation of proteomic samples, protein digest standards for LC-MS quality control, MS-cleavable crosslinkers for protein structure analysis, Heavy Protein in-vitro translation kits for production of stable isotope-labeled proteins; and ActivX Probes for enzyme inhibitor profiling and detection. Currently, Dr. Bomgarden is a Senior Manager of the Mass Spec Reagent group based in Rockford, IL.

      In addition to his work at Thermo Fisher Scientific, Dr. Bomgarden is also an adjunct professor at the University of Illinois College of Medicine where he teaches courses on biochemical techniques, drug design and ethics. Dr. Bomgarden is also heavily involved in STEM education, creating and performing science demonstrations for local non-profit organizations and as a coach for the Winnebago Middle School Science Olympiad team.

    • Max Crispin
      Professor of Glycobiology - University of Southampton, UK
      Biography

        Max read Biochemistry at the University of Oxford as an undergraduate and, after doctoral studies at Oxford and Scripps Research, went on to run the Glycoprotein Therapeutics Laboratory within Oxford’s Department of Biochemistry. Max moved to the University of Southampton in 2017 where he is Professor of Glycobiology. His laboratory operates at the nexus of glycoprotein engineering and glycan analytics and is currently dedicated to the design and analysis of the glycoprotein-based therapies and vaccines. Max’s laboratory is funded by the Bill & Melinda Gates Foundation through the Collaboration for AIDS/Vaccine Discovery, the International AIDS Vaccine Initiative, the US National Institute of Health, the European Union Horizon 2020 programme, and by Against Breast Cancer. He is currently a Supernumerary Fellow at Oriel College, Oxford, and Professor Adjunct in the Department of Immunology and Microbiology at Scripps Research.

      • Tiannan Guo
        Assistant Professor - Westlake University
        Biography

          Tiannan received training of clinical medicine in Tongji Medical College, Huazhong University of Science and Technology (1999-2006), and biology in Wuhan University (2001-2005), before he moved to Singapore for PhD training in cancer proteomics in the laboratories of Dr. Newman Sze in Nanyang Technological University and Dr.Oi Lian Kon in National Cancer Centre Singapore (2008-2012). In 2012, Tiannan started his postdoctoral training in the laboratory of Dr. Ruedi Aebersold in ETH Zurich. In March 2017, Tiannan relocated to ProCan, Children’s Medical Research Institute, The University of Sydney as the Scientific Director. Since August 2017, he became a Tenure Track Assistant Professor in Westlake University, Hangzhou, China. The Guo lab (www.guomics.com) focuses on advancing proteomics technologies for clinical cohort studies.

        • Andreas Hühmer
          Senior Marketing Director of Omics - Thermo Fisher Scientific
          Biography

            Dr. Andreas FR Hühmer is currently the Marketing Director for all things ‘Omics’ at Thermo Fisher Scientific in San Jose, CA. In his current role, he directs the day-to-day marketing business as well as the long-term strategy for the business. He collaborates closely with colleagues in product marketing within the business unit and across the division to deliver innovative and enabling solutions to customers. In a previous role, Dr. Hühmer was instrumental in commercializing the ProteomeX ion trap product, the first highly integrated turn-key solution for Mudpit experiments. He also was responsible for the development of the next generation biosoftware products, such as Proteome Discoverer and SIEVE. Dr. Hühmer holds a PhD (1997) and a Master of Science degree (1996) in Pharmaceutical Chemistry from the University of Kansas. He also received a Bachelor of Science degree (1991) and a Master of Science degree (1993) in Analytical Chemistry from the Free University of Berlin, Germany.

          • Lihua Jiang
            Director - Stanford University
            Biography

              Lihua Jiang is trained in medicine and received her Ph.D. in Analytical Chemistry from Dr. Neil Kelleher’s lab in University of Illinois at Urbana-Champaign. After graduation, she worked in Thermo as an application scientist for about two years. When Dr. Michael Snyder, a world-renowned scientist in genomics, transferred from Yale to Stanford, she decided to join force with him in the emerging field of personalized medicine using Omics technology. In Dr. Snyder’s Lab, she built the platform for both proteomics and metabolomics and published her work in the integrated Personal Omics Profiling (iPOP) paper in Cell (2012). In the past a few years, she led the quantitative proteomics study of the normal human tissues as part of the Genotype-Tissue Expression (GTEx) projects. Her work is just published in Cell. She now directs the Mass Spectrometry Center for Advanced Research in the department of Genetics. She is an expert in mass spectrometry technologies and truly believes that the integration of modern technologies with omics profiling will revolutionize medicine.

            • Neil Kelleher
              Glass Professor of Life Sciences - Northwestern University
              Biography

                Neil L. Kelleher, PhD, is the Walter and Mary Glass Professor of Molecular Biosciences and Professor of Chemistry in the Weinberg College of Arts and Sciences. He also is Director of the Proteomics Center of Excellence and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He has successfully driven technology development and applications of very high performance mass spectrometry in the areas of top down proteomics, natural products discovery, and cancer biology and has over 350 publications, with an H-factor of 70 and more than 1800 citations/year. His outstanding contributions to the fields of proteomics and natural products chemistry have been recognized by multiple awards, including the Biemann Medal from the American Society for Mass Spectrometry, the Pfizer Award in Enzyme Chemistry from the American Chemical Society, the Presidential Early Career Award in Science and Engineering, the Camille Dreyfus Teacher-Scholar Award, a Sloan Fellowship, a Packard Fellowship, and an NSF CAREER Award.

              • Bernhard Kuster
                Professor - Technical University of Munich
                Biography

                  Bernhard Kuster is a chemist by training and obtained is PhD in Biochemistry from the University of Oxford. He did a PostDoc funded by an EMBO long-term fellowship at the EMBL in Heidelberg and the University of Southern Denmark in Odense. After seven years as VP Analytical Sciences and Informatics at the biotech firm Cellzome (now GSK), he became Full Professor and Chair of Proteomics at the Technical University of Munich in 2007. Bernhard is a Carl von Linde Senior Fellow of the TUM Institute for Advanced Study and has received a number of awards in recognition of his contributions to science, including the Discovery in Proteomic Sciences Award of HUPO. His team of biochemists and bioinformaticians was recently awarded an ERC Advanced Grant to research how cancer drugs actually work. Bernhard has also co-founded two start-up companies that operate in the area of proteomics and artificial intelligence.

                • Janne Lehtio
                  Professor - Karolinska Institutet
                  Biography

                    Janne Lehtiö holds faculty professor position in Medical Proteomics at Karolinska Institutet, Stockholm, Sweden and since 2018 he has devoted part of his time as Scientific Director at Science for Life Laboratory, Swedish national laboratories for biosciences. Since 2020, Lehtiö is also serving in board of directors for Karolinska Comprehensive Cancer Center. Prior that he has been principle investigator at Dept. of Oncology and Pathology at Karolinska Institutet and since 2006, Dr. Lehtiö was appointed as director of the Karolinska University Hospital’s clinical proteomics facility. His educational background includes MSc on biochemistry in Helsinki University, Finland and PhD in engineering in Royal Institute of Technology in Stockholm, Sweden. Post the PhD, Lehtiö worked few years in biotech industry in USA and Europe; and obtained postdoctoral experience in in cancer research at Karolinska Institutet. In 2009, Lehtiö got his assistant professor (docent) merit at Karolinska Institutet. Dr Lehtiö’s major research interest is to improve human proteome analysis with the main application focus on precision cancer medicine. The Lehtiö has 130 peer reviewed original publication and together with his group, has published number of novel methods for proteome analysis, data-analysis and cancer research applications in leading journals. The main cancer types that the group focuses are lung and breast cancer as well as on a newly started program on particular childhood and adult leukaemia. Lehtiö has also vast experience on research infrastructures, leading core facilities and national infrastructure initiatives; and was selected as one of the national research infrastructure fellows (including 15 mSEK grant) by The Swedish Foundation for Strategic Research. Moreover, Lehtiö is a co-founder of a biotech company Fenomark Diagnostics. Janne Lehtiö has supervised 15 PhD students and 17 postdoctoral fellows. Lehtiö has a formal university teacher education and is currently lecturing in four graduate programs at KI and frequent lecturer at Swedish universities.

                  • Dani Lopez Ferrer
                    Senior Manager for Proteomics - Thermo Fisher
                    Biography

                      Daniel Lopez-Ferrer is senior manager leading the Proteomics Vertical Marketing team, at Thermo Fisher Scientific. In his current role, Daniel and his team are focused on the identification and development of new proteomics analytical tools and applications that bring broad benefits to the biosciences community. He has held positions as a Senior Scientist at Caprion Proteomics (CA, USA) and Pacific Northwest National Laboratory (WA, USA) developing technologies for high-throughput, large-scale proteomics projects. Dr. Lopez-Ferrer has over 35 peer review papers and several patents.

                    • Gyorgy Marko-Varga
                      Professor - Lund University
                      Biography

                        The major research foci of György Marko-Varga are clinical studies, drug characterisation within cancerous disease and biobanking. The Marko-Varga research group holds >40 scientists. In 2016, the Obama administration and the NIH launched the Cancer Moonshot initiative led by the 47th U.S. Vice President Joe Biden. In 2017, Marko-Varga was appointed the head of the European Cancer Moonshot Center located at Lund University in Sweden. The European hub is aligned with 15 medical centres; in Southern Sweden (10 hospitals), across Europe and Asia. In addition to front-lining cancer research in Europe, Marko-Varga was also responsible for the IRESSA (Gefitinib) and IPASS protein biomarker discovery studies in Japan (2005-2012). The program included 52 lung cancer clinical centres throughout Japan, China, and South Korea. Involving 9,000 patients, this program was the largest ever biomarker study in the field of cancer research. More recently, he was also responsible for biobanking and biomarker developments in the ‘Big 3’ study (2014-2021), with 8,000 patients recruited, where close to 3 million samples were processed so far.

                        Collectively, the established clinical and technological infrastructure, the recruited scientific research team, the collaborations within the pharmaceutical industry, and the connections with oncology centres in Europe and Asia has elevated Marko-Varga to be one of the paramount cancer researchers in Europe and internationally.

                      • David Matthews
                        Reader in Virology - Uni Bristol
                        Biography

                          Dr Matthews gained his PhD from St Andrews University, UK studying adenovirus protein-protein interactions before going to work on adenovirus based gene therapy vectors at McMaster University in Ontario, Canada. He returned to the UK to work on herpesvirus based gene therapy vectors before securing a lectureship in virology at the University of Bristol. Here he returned to work on adenoviruses studying how adenovirus affects the nucleolar proteome and how the use of next generation transcriptomics can be used to inform a deeper understanding of proteomics and host cell changes in response to viral infection. He has since worked on a number of zoonotic viral diseases including Hendra virus, Ebola, MERS-CoV and currently SARS-CoV-2.

                        • Valdemir Melechco Carvalho
                          Senior Scientist - Fleury Group
                          Biography

                            Valdemir Melechco Carvalho received his Ph.D. in Biochemistry from the University of São Paulo. He joined Fleury Group in 2001 where he is a Senior Scientist and leads a team focused on the development of applications of chromatography and mass spectrometry to clinical analysis. He is also a professor at the Clinical and Toxicology Sciences graduate program at the Pharmaceutical Sciences School of the University of São Paulo.

                          • Lukas Reiter
                            Chief Technology Officer - Biognosys AG
                            Biography

                              Lukas graduated from ETH Zurich in molecular biology. For his PhD, he joined the groups of geneticist Michael Hengartner and proteomics pioneer Ruedi Aebersold and received his degree in 2009 from the University of Zurich. After that Lukas joined Biognosys in 2010 as one if its first employees. As CTO, he oversees research as well as product and workflow development at Biognosys.

                            • Erwin Schoof
                              Associate Professor - Copenhagen University
                              Biography

                                Dr. Erwin Schoof heads the DTU Proteomics Facility while pursuing an academic career in cancer stem cell biology. He holds an appointment as Associate Professor at DTU, focusing on cell heterogeneity within normal and malignant hematopoiesis.

                              • Lauren Stopfer
                                Graduate Student - Koch Institute for Integrative Cancer Research & MIT
                                Biography

                                  Lauren received her B.S. in Biomedical Engineering at the University of Wisconsin-Madison in 2015 and is currently finishing her Bioengineering PhD at MIT in Forest White’s lab. Her research focuses on developing and applying novel quantitative mass spectrometry methods in the fields on antigen presentation and phosphorylation signaling dynamics, with the goal of gaining unique biological insights across cancer types.

                                • Danielle Swaney
                                  Assistant Professor - UCSF
                                  Biography

                                    Danielle Swaney obtained her PhD in analytical chemistry in the laboratory of Joshua Coon at the University of Wisconsin, where she focused on methods developments in the areas of phosphoproteomics and electron transfer dissociation. She then spent 4 year as a post-doctoral fellow at the University of Washington in the lab of Judit Villen, where she develop approaches to study post-translational modification crosstalk. In 2015, Danielle joined as a faculty member at UCSF, where she has worked in close collaboration with the lab of Nevan Krogan to apply proteomics towards the study of host-pathogen biology.

                                  • Nicola Ternette
                                    Associate Professor - University of Oxford
                                    Biography

                                      Dr. Nicola Ternette trained in Physics and Biochemistry at the Universities of Bonn, Greifswald and Bochum in Germany. She pursued her post-graduate studies in developing and evaluating DNA vaccines for Respiratory Syncytial Virus (RSV) at the Institute for Molecular and Medical Virology in Bochum. Following her PhD, she continued her research on viral infection at the University of Oxford. She specialized in sequencing of HLA-associated peptidomes using nanoflow ultra-performance liquid chromatography tandem mass spectrometry (LC-MS) with the focus on identification of viral antigens for the development of T cell vaccines for HIV-1. Since 2015, she is heading the Antigen Discovery Group at Oxford. Her group has expanded their expertise to deep sequencing of immunopeptidomes in multiple pathogen infection models, analysis of the antigenic landscape of solid tumours and haematological cancers and characterisation of antigens involved in autoimmune diseases.

                                    • Mathias Wilhelm
                                      Chair of Proteomics and Bioanalytics - Technical University of Munich
                                      Biography

                                        Mathias Wilhelm is a trained bioinformatician but generally intrigued by all mechanisms which require a good understanding of mathematics, physics, chemistry and biology. Initially working in the field of metabolomics, he spent the last 7 years of his scientific career focusing on studying the life-cycle of proteins using mass spectrometry. Today, he leads a small group of bioinformaticians at the Chair of Proteomics and Bioanalytics (Prof. Bernhard Kuster, Technical University Munich) and is interested in supporting wet-lab scientists by developing tools for data analysis, integration, interpretation and dissemination. In addition, he is a co-founder of OmicScouts GmbH and MSAID GmbH, both providing services in the field of mass spectromtery-based proteomics.

                                      About Us

                                      Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

                                       

                                      Help

                                      General LabRoots Questions

                                      email support@labroots.com  

                                      Virtual Events and Webinars

                                      Supported Configurations

                                      • Operating System Internet Explorer Firefox Chrome Safari
                                        Vista IE8+ FF10+ Chrome15+
                                        Windows 7 IE8+ FF10+ Chrome15+
                                        Windows 8 IE10 FF10+ Chrome15+
                                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                                      • Cookie settings: session cookies enabled
                                      • Browser configuration must have JavaScript enabled
                                      • Adobe Flash player 10.2 or later

                                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                      Internet Connection

                                      • A minimum of 100Kbps is recommended for audio-only events
                                      • A minimum of 300Kbps is recommended for speaker on-video events

                                      Computer Equipment

                                      • Screen Resolution: Minimum 1024x768
                                      • Video Card: 65,000 colors minimum
                                      • Sound card and speakers (or headphones) for hearing webcast in full format
                                      • Audio Card: 16-bit minimum
                                      • RAM: 512MB of free RAM

                                      Firewall Protocol

                                      • HTTP on port 80 or HTTPS on port 443
                                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                      Work-At-Home Attendees

                                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                      For A Seamless Experience

                                      When using a mobile device, FREE Mobile Apps are available:

                                      - For viewing Webinars:

                                      - For viewing Virtual Events

                                      Attendee Guide

                                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                      Virtual Event and Webinar Support:

                                      Continuing Education (CME/CE) Support

                                      Loading Comments...
                                      Show Resources
                                      Attendees
                                      • See more